Cart (0 Items)
Your cart is currently empty.
View ProductsDuligotuzumab Biosimilar – Anti-ERBB3 mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Duligotuzumab Biosimilar - Anti-ERBB3 mAb - Research Grade |
|---|---|
| Source | CAS 1314238-96-4 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | ELISA,WB |
| Aliases /Synonyms | Duligotuzumab,MEHD7945A,RG-7597,ERBB3 ,anti-ERBB3 |
| Reference | PX-TA1290 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Duligotuzumab Biosimilar - Anti-ERBB3 mAb - Research Grade
General information on Anti-ERBB3 [Homo sapiens] (Duligotuzumab) Monoclonal Antibody
Duligotuzumab has beeninvestigated for the treatment of Neoplasms, Colorectal Cancer, Head and Neck Cancer, and Epithelial Tumors.
Related products
Antigen
Receptor tyrosine-protein kinase erbB-3(ERBB3)Fc Tag
PX-P4725 210€
SIL
Reviews
Il n’y a pas encore d’avis.